BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15129986)

  • 1. Evaluation of xanthan and highly substituted galactomannan from M. scabrella as a sustained release matrix.
    Ughini F; Andreazza IF; Ganter JL; Bresolin TM
    Int J Pharm; 2004 Mar; 271(1-2):197-205. PubMed ID: 15129986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthan and galactomannan (from M. scabrella) matrix tablets for oral controlled delivery of theophylline.
    Vendruscolo CW; Andreazza IF; Ganter JL; Ferrero C; Bresolin TM
    Int J Pharm; 2005 May; 296(1-2):1-11. PubMed ID: 15885450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Mimosa pudica seed mucilage as sustained-release excipient.
    Singh K; Kumar A; Langyan N; Ahuja M
    AAPS PharmSciTech; 2009; 10(4):1121-7. PubMed ID: 19763837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in-vitro in-vivo evaluation of sustained release matrix diclofenac sodium tablets using PVP-K90 and natural gums.
    Iqbal Z; Khan R; Nasir F; Khan JA; Rashid A; Khan A; Khan A
    Pak J Pharm Sci; 2011 Oct; 24(4):435-43. PubMed ID: 21959802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of galactomannan composition on the binary gel formation with xanthan.
    Bresolin TM; Milas M; Rinaudo M; Reicher F; Ganter JL
    Int J Biol Macromol; 1999 Dec; 26(4):225-31. PubMed ID: 10569283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Prosopis africana Seed Gum as an Extended Release Polymer for Tablet Formulation.
    Nadaf S; Nnamani P; Jadhav N
    AAPS PharmSciTech; 2015 Jun; 16(3):716-29. PubMed ID: 25523143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulations of zero-order, pH-dependent, sustained release matrix systems by ionotropic gelation of alginate-containing mixtures.
    Moroni A; Drefko W; Thone G
    Drug Dev Ind Pharm; 2011 Feb; 37(2):216-24. PubMed ID: 20973612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of natural gums and cellulose derivatives in production of sustained release metoprolol tablets.
    Varshosaz J; Tavakoli N; Eram SA
    Drug Deliv; 2006; 13(2):113-9. PubMed ID: 16423799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on drug release from aminophylline konjac glucomannan matrix tablet].
    Zhu GQ; Zhang Y; Liu JH
    Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(21):2236-9. PubMed ID: 18309662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
    Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
    Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthan-alginate composite gel beads: molecular interaction and in vitro characterization.
    Pongjanyakul T; Puttipipatkhachorn S
    Int J Pharm; 2007 Feb; 331(1):61-71. PubMed ID: 17046185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained-release and swelling characteristics of xanthan gum/ethylcellulose-based injection moulded matrix tablets: in vitro and in vivo evaluation.
    Quinten T; De Beer T; Onofre FO; Mendez-Montealvo G; Wang YJ; Remon JP; Vervaet C
    J Pharm Sci; 2011 Jul; 100(7):2858-70. PubMed ID: 21254067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compaction, compression and drug release properties of diclofenac sodium and ibuprofen pellets comprising xanthan gum as a sustained release agent.
    Santos H; Veiga F; Pina ME; Sousa JJ
    Int J Pharm; 2005 May; 295(1-2):15-27. PubMed ID: 15898143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride.
    Varshosaz J; Tavakoli N; Kheirolahi F
    AAPS PharmSciTech; 2006 Mar; 7(1):E24. PubMed ID: 16584155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compressed xanthan and karaya gum matrices: hydration, erosion and drug release mechanisms.
    Munday DL; Cox PJ
    Int J Pharm; 2000 Aug; 203(1-2):179-92. PubMed ID: 10967440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.
    Abdullah MD; Bepary S; Rouf AS
    Pak J Pharm Sci; 2008 Jan; 21(1):70-7. PubMed ID: 18166523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
    Rajesh KS; Venkataraju MP; Gowda DV
    Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheological characterization of O/W emulsions incorporated with neutral and charged polysaccharides.
    Vianna-Filho RP; Petkowicz CL; Silveira JL
    Carbohydr Polym; 2013 Mar; 93(1):266-72. PubMed ID: 23465929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium.
    Al-Taani BM; Tashtoush BM
    AAPS PharmSciTech; 2003; 4(3):E43. PubMed ID: 14621975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.